- Home
- HE vs WGS Comparison
HE vs WGS Comparison
Compare HE & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HE
- WGS
- Stock Information
- Founded
- HE 1891
- WGS 2017
- Country
- HE United States
- WGS United States
- Employees
- HE N/A
- WGS N/A
- Industry
- HE Electric Utilities: Central
- WGS Retail: Computer Software & Peripheral Equipment
- Sector
- HE Utilities
- WGS Technology
- Exchange
- HE Nasdaq
- WGS Nasdaq
- Market Cap
- HE 2.1B
- WGS 2.4B
- IPO Year
- HE N/A
- WGS N/A
- Fundamental
- Price
- HE $12.19
- WGS $122.04
- Analyst Decision
- HE Hold
- WGS Strong Buy
- Analyst Count
- HE 4
- WGS 7
- Target Price
- HE $10.94
- WGS $102.14
- AVG Volume (30 Days)
- HE 2.1M
- WGS 579.2K
- Earning Date
- HE 11-07-2025
- WGS 10-28-2025
- Dividend Yield
- HE N/A
- WGS N/A
- EPS Growth
- HE N/A
- WGS N/A
- EPS
- HE N/A
- WGS 0.05
- Revenue
- HE $3,122,881,000.00
- WGS $362,321,000.00
- Revenue This Year
- HE $12.58
- WGS $35.84
- Revenue Next Year
- HE $2.10
- WGS $18.46
- P/E Ratio
- HE N/A
- WGS $2,541.32
- Revenue Growth
- HE 2.36
- WGS 48.70
- 52 Week Low
- HE $8.14
- WGS $35.88
- 52 Week High
- HE $13.41
- WGS $136.00
- Technical
- Relative Strength Index (RSI)
- HE 56.73
- WGS 52.27
- Support Level
- HE $12.01
- WGS $120.55
- Resistance Level
- HE $12.20
- WGS $129.25
- Average True Range (ATR)
- HE 0.33
- WGS 5.28
- MACD
- HE -0.07
- WGS -2.01
- Stochastic Oscillator
- HE 26.65
- WGS 9.64
About HE Hawaiian Electric Industries Inc.
Hawaiian Electric Industries is the parent company of three Hawaii-based regulated utilities and owns a 10% minority interest in Hawaii's American Savings Bank. The utilities provide electricity on the five islands of Oahu, Hawaii, Maui, Molokai, and Lanai.
About WGS GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.